Ca2+ signaling through ryanodine receptor 1 enhances maturation and activation of human dendritic cells

Journal of Cell Science

Volumn 120, Issue 13, 2007, Pages 2232-2240

  Bracci, Laura ^a,c   Vukcevic, Mirko ^a   Spagnoli, Giulio ^a   Ducreux, Sylvie ^a   Zorzato, Francesco ^b   Treves, Susan ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF FERRARA   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Dendritic cell; Maturation; Ryanodine receptor; Signaling

Indexed keywords

CAFFEINE; CALCIUM; RYANODINE RECEPTOR 1; TOLL LIKE RECEPTOR; RYANODINE RECEPTOR;

ANTIGEN PRESENTING CELL; ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL MATURATION; CELL MIGRATION; DENDRITIC CELL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; CELL CULTURE; CELL MOTION; CYTOLOGY; METABOLISM; PHYSIOLOGY;

CALCIUM SIGNALING; CELL MOVEMENT; CELLS, CULTURED; DENDRITIC CELLS; HUMANS; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; TOLL-LIKE RECEPTORS;

EID: 34447509793     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.007203     Document Type: Article

References (47)

1. Banchereau, J. and Steinman, R. M. (1998). Dendritic cells and the control of immunity. Nature 392, 245-252.
2. Barford, D. (1996). Molecular mechanisms of the protein serine/ threonine phosphatases. Trends Biochem. Sci. 21, 407-412.
3. Barone, J. J. and Roberts, H. R. (1996). Caffeine consumption. Food Chem. Toxicol. 34, 119-129.
4. Berridge, M., Bootman, M. D. and Roderick, H. L. (2003). Calcium signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 4, 517-529.
5. Bers, D. M. (2004). Macromolecular complexes regulating cardiac ryanodine receptor function. J. Mol. Cell. Cardiol. 37, 417-429.
6. Ciesek, S., Ringe, B. P., Strassburg, C. P., Klempnauer, J., Manns, M. P., Wedemeyer, H. and Becker, T. (2005). Effects of cyclosporine on human dendritic cell subsets. Transplant. Proc. 27, 20-24.
7. Czerniecki, B. J., Carter, C., Rivoltini, L., Koski, G. K. H., Kim, I., Weng, D. E., Roros, J. G., Hijazi, Y. M., Xu, S., Rosenberg, S. A. et al. (1997). Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells. J. Immunol. 159, 3823-3837.
8. 2+ response amplitude and duration. Nature 386, 856-858.
9. Ducreux, S., Zorzato, F., Müller, C. R., Sewry, C., Muntoni, F., Quinlivan, R., Restagno, G., Girard, T. and Treves, S. (2004). Effect of ryanodine receptor mutations on interleukin-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia-susceptible individuals and patients affected by central core disease. J. Biol. Chem. 2279, 43838-43846.
10. Enan, E. and Matsumara, F. (1992). Specific inhibition of calcineurin by type II synthetic pyrethroid insecticides. Biochem. Pharmacol. 15, 1777-1794.
11. Faries, M. B., Bedrosian, I., Xu, S., Koski, G., Roros, J. G., Moise, M. A., Nguyen, H. Q., Friederike, H., Engels, H. C., Cohen, P. A. et al. (2001). Calcium signaling inhibits interleukin-12 production and activates CD83(+) dendritic cells that induce Th2 cell development. Blood 98, 2489-2497.
12. Franzini-Armstrong, C. and Protasi, F. (1997). Ryanodine receptors of striated muscles: a complex channel capable of multiple interactions. Physiol. Rev. 77, 699-729.
13. Gardella, S., Andrei, C., Lotti, L. V., Poggi, A., Torrisi, M. R., Zocchi, M. R. and Rubarteli, A. (2001). CD8(+) T lymphocytes induce polarized exocytosis of secretory lysosomes by dendritic cells with release of interleukin-1beta and cathepsin D. Blood 98, 2152-2159.
14. Ghosh, S., May, M. J. and Kopp, E. B. (1998). NF-kB and Rel proteins: evolutionary conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260.
15. Girard, T., Cavagna, D., Padovan, E., Spagnoli, G., Urwyler, A., Zorzato, F. and Treves, S. (2001). B-lymphocytes from malignant hyperthermia-susceptible patients have an increased sensitivity to skeletal muscle ryanodine receptor activators. J. Biol. Chem. 276, 48077-48082.
16. Goth, S. R., Chu, R. A., Gregg, J. P., Cjerednichenko, G. and Pessah, I. N. (2006). Uncoupling of ATP-mediated calcium signaling and dysregulated interleukin-6 secretion in dendritic cells by nanomolar thimerosal. Environ. Health Perspect. 114, 1083-1091.
17. Grohmann, U., Belladonna, M. L., Bianchi, R., Orabona, C., Ayroldi, E., Fioretti, M. C. and Puccetti, P. (1998). IL-12 acts directly on DC to promote nuclear translocation of NF-kB and primes DC for IL-12 production. Immunity 9, 315-323.
18. Iwasaki, A. and Kelsall, B. L. (1999). Mucosal immunity and inflammation. I. Mucosal dendritic cells: their specialized role in initiating T cell responses. Am. J. Physiol. 276, G1074-G1078.
19. Hosoi, E., Nishizaki, C., Gallagher, K. L., Wyre, H. W., Matsuo, Y. and Sei, Y. (2001). Expression of the ryanodine receptor isoforms in immune cells. J. Immunol. 167, 4887-4894.
20. Koski, G. K., Schwartz, G. N., Weng, D. E., Czerniecki, B. J., Carter, C., Gress, R. E. and Cohen, P. A. (1999). Calcium mobilization in human myeloid cells results in acquisition of individual dendritic cell-like characteristics through discrete signaling pathways. J. Immunol. 163, 82-92.
21. Lachmann, M., Berchtold, S., Hauber, J. and Steinkasserer, A. (2002). CD93 on dendritic cells: more than just a marker for maturation. Trends Immunol. 23, 273-275.
22. Lee, J., Ganster, R. W., Geller, D. A., Burckart, G. J., Thomson, A. W. and Lu, L. (1999). Cyclosporine A inhibits the expression of co-stimulatory molecules on in vitro-generated dendritic cells. Transplantation 68, 1255-1263.
23. Li-Weber, M., Giasi, M., Baumann, S., Palfi, K. and Krammer, P. H. (2004). NF-kB synergizes with NF-AT and NF-IL6 in activation of the IL-4 gene in T cells. Eur. J. Immunol. 34, 1111-1118.
24. 2+ release channel, J. Biol. Chem. 268, 13765-13769.
25. Mohty, M., Isnardon, D., Charbonnier, A., Lafag-Pochitaloff, M., Merlin, M., Sainty, D., Olive, D. and Gaugler, B. (2002). Generation of potent T(h)1 responses from patients with lymphoid malignancies after differentiation of B lymphocytes into dendritic-like cell. Int. Immunol. 14, 741-750.
26. O'Connell, P. J., Klyachko, V. A. and Ahern, G. P. (2002). Identification of functional type 1 ryanodine receptors in mouse dendritic cells. FEBS Lett. 512, 67-70.
27. 2+ release channel (ryanodine receptor) of rabbit cardiac muscle sarcoplasmic reticulum. J. Biol. Chem. 265, 13472-13483.
28. Phillips, M., Fujii, J., Khanna, V. K., DeLeon, S., Yokobata, K., de Jong, P. J. and MacLennan, D. H. (1996). The structural organization of the human skeletal muscle ryanodine receptor (RYR1) gene. Genomics 34, 24-41.
29. Ralevie, R. and Burnstock, G. (1998). Receptors for purines and pyrimidines. Pharmacol. Rev. 50, 413-455.
30. Sallusto, F. and Lanzavecchia, A. (1994). Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179, 1109-1118.
31. Sallusto, F., Schaerli, P., Loetscher, P., Schaniel, C., Lenig, D., Mackay, C. R., Qin, S. and Lanzavecchia, A. (1998). Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 28, 2760-2769.
32. Samso, M., Wagenknecht, T. and Allen, P. D. (2005). Internal structure and visualization of transmembrane domains of the RyR1 calcium release channel by cryo-EM. Nat. Stuct. Mol. Biol. 12, 539-544.
33. Sauter, B. B., Albert, M. L., Francisco, L., Larsson, M., Somersan, S. and Bhardwaj, N. (2000). Consequences of cell death: exposure to necrotic tumor cells but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191, 423-433.
34. Schnurr, M., Shin, A., Hartmann, G., Rothenfusser, S., Soellner, J., Davis, I. D., Cebon, J. and Maraskovsky, E. (2004). Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cells. Blood 103, 1391-1397.
35. Sei, Y., Gallagher, K. L. and Basile, A. S. (1999). Skeletal muscle type ryanodine receptor is involved in calcium signaling in human B lymphocytes. J. Biol. Chem. 274, 5995-6002.
36. 2+ release channel at 14 A resolution. J. Mal. Biol. 21, 427-431.
37. Sorrentino, V., Giannini, G., Malzac, P. and Mattei, M. G. (1993). Localization of a novel ryanodine receptor gene (RYR3) to human chromosome 15q14-q15 by in situ hybridization. Genomics 18, 163-165.
38. 2+ signaling in the absence of RyR1. J. Leuk. Biol. 80, 651-658.
39. 2+ release channels: does diversity in form equal diversity in function? Physiol. Rev. 76, 1027-1071.
40. Tajima, K., Amakawa, R., Ito, T., Miyaji, M. and Takebayashi, M. (2003). Immunomodulatory effects of cyclosporine A on peripheral blood dendritic cell subsets. Immunology 108, 321-328.
41. Takeshima, H., Nishimura, S., Matsumoto, T., Ishida, H., Kangawa, K., Minamino, N., Matsuo, H., Ueda, M., Hanaoka, M., Hirose, T. et al. (1989). Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature 339, 439-445.
42. Tarroni, P.., Rossi, D., Conti, A. and Sorrentino, V. (1997). Expression of the ryanodine receptor type 3 calcium release channel during development and differentiation of mammalian skeletal muscle cells. J. Biol. Chem. 272, 19808-19813.
43. Treves, S., Anderson, A. A., Ducreux, S., Divet, A., Bleuven, C., Grasso, C., Paesante, S. and Zorzato, F. (2005). Ryanodine receptor 1 mutations, dysregulation of calcium homeostasis and neuromuscular disorders. Neuromuscul. Disord. 15, 577-587.
44. 2+ release channels. Molecular mechanism and isoform selectivity. J. Biol. Chem. 276, 13810-13816.
45. Zhou, L. J. and Tedder, T. F. (1996). CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc. Natl. Acad. Sci. USA 93, 2588-2592.
46. 2+ release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum. J. Biol. Chem. 265, 2244-2256.
47. 2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease states. Pharmacol. Rev. 49, 1-51.